Renxiang Yuan
Overview
Explore the profile of Renxiang Yuan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
27
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang D, Jiang Q, Li P, Yu C, Yuan R, Dong Z, et al.
ACS Appl Mater Interfaces
. 2025 Feb;
17(7):10986-11001.
PMID: 39931937
Inflammatory bowel disease (IBD) presents a significant challenge in healthcare, characterized by its chronicity and complex pathogenesis involving genetic, immune, and environmental factors. Current treatment modalities, including anti-inflammatory drugs, immunomodulators,...
2.
Wu X, Yuan R, Xu Y, Wang K, Yuan H, Meng T, et al.
Asian J Pharm Sci
. 2024 Apr;
19(2):100904.
PMID: 38601010
The challenge in the clinical treatment of Parkinson's disease lies in the lack of disease-modifying therapies that can halt or slow down the progression. Peptide drugs, such as exenatide (Exe),...
3.
Yang Y, Yuan R, Lu Y, Zhu C, Zhang C, Lue H, et al.
CNS Neurosci Ther
. 2023 Jul;
29(12):3684-3692.
PMID: 37438945
Aims: Mania is a prevalent psychiatric disorder with undefined pathological mechanism. Here, we reviewed current knowledge indicating the potential involvement of autophagy dysregulation in mania and further discussed whether targeting...
4.
Xue H, Lu J, Yuan R, Liu J, Liu Y, Wu K, et al.
Cell Biosci
. 2016 Jan;
6:5.
PMID: 26816615
Background: Human head and neck squamous carcinoma is the 6th most prevalent carcinoma worldwide. Although many novel therapies have been developed, the clinical treatment for patients remains non-ideal. Chloride intracellular...